Vimarsana
Biggest News Aggregation in the World

Robert Cuddihy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Cuddihy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Cuddihy Today - Breaking & Trending Today

This Gas Station Freebie Will Change Your Backcountry Hydration - Vimarsana News

This Gas Station Freebie Will Change Your Backcountry Hydration

Our hiking columnist loves the simplicity and familiarity of a flavor additive called True Lemon, which lurks in the condiment zone of rest stops

Source: yahoo.com
This Gas Station Freebie Will Change Your Backcountry Hydration - Vimarsana News

This Gas Station Freebie Will Change Your Backcountry Hydration

Our hiking columnist likes the simplicity and availability of a drink additive called True Lemon, which can be found at most rest stops

True Citrus Becomes First Brand to Surpass $2 Million in Sales Booked on Grovara's B2B Global Wholesale Marketplace - Vimarsana News

True Citrus Becomes First Brand to Surpass $2 Million in Sales Booked on Grovara's B2B Global Wholesale Marketplace

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Capsida Names C-Level Execs | San Fernando Valley Business Journal - Vimarsana News

Capsida Names C-Level Execs | San Fernando Valley Business Journal

Thousand Oaks-based gene therapy company Capsida Biotherapeutics on Tuesday announced the appointment of Peter Anastasiou as its chief executive officer effective Jan. 3.

Source: sfvbj.com
Capsida unveils $140M, AbbVie alliance & tech that takes gene therapy to the brain - Vimarsana News

Capsida unveils $140M, AbbVie alliance & tech that takes gene therapy to the brain

MedCity News Capsida unveils $140M, AbbVie alliance & tech that takes gene therapy to the brain Capsida Biotherapeutics’ technology can engineer viral vectors that deliver gene therapies to central nervous system cells. With that capability, the startup was able to raise $50 million in Series A financing and a multi-drug research alliance AbbVie. Shares1   Gene therapy developers rely on engineered viruses to carry genetic cargo to cells. Adeno-associated virus, the viral vector that has been the backbone of this burgeoning field, shows a particular preference for targeting liver cells. ...